{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T06:33:47Z","timestamp":1773297227566,"version":"3.50.1"},"reference-count":45,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1 TR002535"],"award-info":[{"award-number":["UL1 TR002535"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016062","name":"Stichting Metakids","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.ymgme.2022.02.005","type":"journal-article","created":{"date-parts":[[2022,2,17]],"date-time":"2022-02-17T03:48:48Z","timestamp":1645069728000},"page":"350-356","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Timing of therapy and neurodevelopmental outcomes in 18 families with pyridoxine-dependent epilepsy"],"prefix":"10.1016","volume":"135","author":[{"given":"Laura A.","family":"Tseng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose E.","family":"Abdenur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashley","family":"Andrews","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Verena G.","family":"Aziz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Levinus A.","family":"Bok","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica","family":"Boyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Buhas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans","family":"Hartmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emma J.","family":"Footitt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabine","family":"Gr\u00f8nborg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mirian C.H.","family":"Janssen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicola","family":"Longo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roelineke J.","family":"Lunsing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alex E.","family":"MacKenzie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frits A.","family":"Wijburg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr","given":"Sidney M.","family":"Gospe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"II","given":"Curtis R.","family":"Coughlin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clara D.M.","family":"van Karnebeek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2022.02.005_bb0005","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/jimd.12045","article-title":"The genotypic spectrum of ALDH7A1 mutations resulting in pyridoxine dependent epilepsy: a common epileptic encephalopathy","volume":"42","author":"Coughlin","year":"2019","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2022.02.005_bb0010","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1136\/adc.2005.075069","article-title":"Epidemiology of pyridoxine dependent seizures in the Netherlands","volume":"90","author":"Been","year":"2005","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.ymgme.2022.02.005_bb0015","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1542\/peds.13.2.140","article-title":"Pyridoxine dependency: report of a case of intractable convulsions in an infant controlled by pyridoxine","volume":"13","author":"Hunt","year":"1954","journal-title":"Pediatrics"},{"key":"10.1016\/j.ymgme.2022.02.005_bb0020","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/s00431-008-0823-x","article-title":"Clinical features and the management of pyridoxine-dependent and pyridoxine-responsive seizures: review of 63 North American cases submitted to a patient registry","volume":"168","author":"Basura","year":"2009","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.ymgme.2022.02.005_bb0025","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s11011-017-0150-x","article-title":"Pyridoxine-dependent epilepsies: an observational study on clinical, diagnostic, therapeutic and prognostic features in a pediatric cohort","volume":"33","author":"Falsaperla","year":"2018","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.ymgme.2022.02.005_bb0030","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.seizure.2018.03.010","article-title":"Atypical pyridoxine dependent epilepsy resulting from a new homozygous missense mutation, in ALDH7A1","volume":"57","author":"Haidar","year":"2018","journal-title":"Seizure"},{"key":"10.1016\/j.ymgme.2022.02.005_bb0035","article-title":"Clinical and genetic features in pyridoxine-dependent epilepsy: a Chinese cohort study","author":"Jiao","year":"2019","journal-title":"Dev. Med. Child Neurol."},{"key":"10.1016\/j.ymgme.2022.02.005_bb0040","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1055\/s-0037-1621721","article-title":"Antiquitin deficiency with adolescent onset epilepsy: molecular diagnosis in a mother of affected offsprings","volume":"49","author":"Srinivasaraghavan","year":"2018","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.ymgme.2022.02.005_bb0045","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.pediatrneurol.2015.12.013","article-title":"Pyridoxine-dependent epilepsy: an expanding clinical Spectrum","volume":"59","author":"van Karnebeek","year":"2016","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.ymgme.2022.02.005_bb0050","article-title":"Consensus guidelines for the diagnosis and management of pyridoxine-dependent epilepsy due to \u03b1-aminoadipic semialdehyde dehydrogenase deficiency","author":"Coughlin","year":"2020","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2022.02.005_bb0055","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1111\/j.1469-8749.2012.04347.x","article-title":"Long-term outcome in pyridoxine-dependent epilepsy","volume":"54","author":"Bok","year":"2012","journal-title":"Dev. Med. Child Neurol."},{"key":"10.1016\/j.ymgme.2022.02.005_bb0060","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s11011-016-9933-8","article-title":"Phenotype, biochemical features, genotype and treatment outcome of pyridoxine-dependent epilepsy","volume":"32","author":"Al Teneiji","year":"2017","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.ymgme.2022.02.005_bb0065","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nm1366","article-title":"Mutations in antiquitin in individuals with pyridoxine-dependent seizures","volume":"12","author":"Mills","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymgme.2022.02.005_bb0070","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/1531-8249(200007)48:1<121::AID-ANA20>3.0.CO;2-V","article-title":"Pipecolic acid elevation in plasma and cerebrospinal fluid of two patients with pyridoxine-dependent epilepsy","volume":"48","author":"Plecko","year":"2000","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ymgme.2022.02.005_bb0075","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1007\/s10545-011-9443-0","article-title":"The measurement of urinary \u03941-piperideine-6-carboxylate, the alter ego of \u03b1-aminoadipic semialdehyde, in antiquitin deficiency","volume":"35","author":"Struys","year":"2012","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2022.02.005_bb0080","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1002\/jimd.12059","article-title":"Identification of a novel biomarker for pyridoxine-dependent epilepsy: implications for newborn screening","volume":"42","author":"Wempe","year":"2019","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2022.02.005_bb0085","article-title":"Identification of novel biomarkers for pyridoxine-dependent epilepsy using untargeted metabolomics and infrared ion spectroscopy - biochemical insights and clinical implications","author":"Engelke","year":"2021","journal-title":"MedRxiv."},{"key":"10.1016\/j.ymgme.2022.02.005_bb0090","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1002\/jimd.12060","article-title":"Disorders affecting vitamin B6 metabolism","volume":"42","author":"Wilson","year":"2019","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2022.02.005_bb0095","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ymgme.2011.05.014","article-title":"Pyridoxine dependent epilepsy and antiquitin deficiency: clinical and molecular characteristics and recommendations for diagnosis, treatment and follow-up","volume":"104","author":"Stockler","year":"2011","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2022.02.005_bb0100","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.ymgme.2012.09.006","article-title":"Lysine restricted diet for pyridoxine-dependent epilepsy: first evidence and future trials","volume":"107","author":"van Karnebeek","year":"2012","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2022.02.005_bb0105","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.ejpn.2014.07.001","article-title":"Novel therapy for pyridoxine dependent epilepsy due to ALDH7A1 genetic defect: L-arginine supplementation alternative to lysine-restricted diet","volume":"18","author":"Mercimek-Mahmutoglu","year":"2014","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"10.1016\/j.ymgme.2022.02.005_bb0110","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ymgme.2015.05.011","article-title":"Triple therapy with pyridoxine, arginine supplementation and dietary lysine restriction in pyridoxine-dependent epilepsy: neurodevelopmental outcome","volume":"116","author":"Coughlin","year":"2015","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2022.02.005_bb0115","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1007\/s10803-017-3137-x","article-title":"Broad cognitive profile in children and adolescents with HF-ASD and in their siblings: widespread underperformance and its clinical and adaptive correlates","volume":"47","author":"Rosa","year":"2017","journal-title":"J. Autism Dev. Disord."},{"key":"10.1016\/j.ymgme.2022.02.005_bb0120","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1111\/jcpp.12362","article-title":"Exploring the cognitive features in children with autism spectrum disorder, their co-twins, and typically developing children within a population-based sample","volume":"56","author":"Brunsdon","year":"2015","journal-title":"J. Child Psychol. Psychiatry"},{"key":"10.1016\/j.ymgme.2022.02.005_bb0125","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/S0140-6736(74)91873-X","article-title":"Natural history of phenylketonuria and influence of early treatment","volume":"2","author":"Smith","year":"1974","journal-title":"Lancet"},{"key":"10.1016\/j.ymgme.2022.02.005_bb0130","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.jpeds.2008.11.052","article-title":"Outcomes of siblings with classical galactosemia","volume":"154","author":"Hughes","year":"2009","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgme.2022.02.005_bb0135","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)\u2013a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J. Biomed. Inform."},{"key":"10.1016\/j.ymgme.2022.02.005_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbi.2019.103208","article-title":"REDCap consortium, the REDCap consortium: building an international community of software platform partners","volume":"95","author":"Harris","year":"2019","journal-title":"J. Biomed. Inform."},{"key":"10.1016\/j.ymgme.2022.02.005_bb0145","doi-asserted-by":"crossref","first-page":"e2016","DOI":"10.1542\/peds.2013-1056","article-title":"Neuromotor screening expert panel, motor delays: early identification and evaluation","volume":"131","author":"Noritz","year":"2013","journal-title":"Pediatrics"},{"key":"10.1016\/j.ymgme.2022.02.005_bb0150","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.e8687","article-title":"Developmental assessment of children","volume":"346","author":"Bellman","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.ymgme.2022.02.005_bb0155","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.0020041","article-title":"Assumption-free estimation of heritability from genome-wide identity-by-descent sharing between full siblings","volume":"2","author":"Visscher","year":"2006","journal-title":"PLoS Genet."},{"key":"10.1016\/j.ymgme.2022.02.005_bb0160","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.jpeds.2015.12.027","article-title":"Neurodevelopmental outcome and treatment efficacy of benzoate and dextromethorphan in siblings with attenuated nonketotic hyperglycinemia","volume":"170","author":"Bjoraker","year":"2016","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgme.2022.02.005_bb0165","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s13023-015-0344-4","article-title":"Ivanovska holder, early treatment with laronidase improves clinical outcomes in patients with attenuated MPS I: a retrospective case series analysis of nine sibships","volume":"10","author":"Al-Sannaa","year":"2015","journal-title":"Orphanet J Rare Dis."},{"key":"10.1016\/j.ymgme.2022.02.005_bb0170","doi-asserted-by":"crossref","DOI":"10.1007\/s11011-016-9869-z","article-title":"Pyridoxine-dependent epilepsy: report on three families with neuropathology","author":"Marguet","year":"2016","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.ymgme.2022.02.005_bb0175","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1093\/brain\/awq143","article-title":"Genotypic and phenotypic spectrum of pyridoxine-dependent epilepsy (ALDH7A1 deficiency)","volume":"133","author":"Mills","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.ymgme.2022.02.005_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejpn.2018.06.010","article-title":"Brain malformations associated to Aldh7a1 gene mutations: report of a novel homozygous mutation and literature review","author":"Toldo","year":"2018","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"10.1016\/j.ymgme.2022.02.005_bb0185","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2021.644447","article-title":"Analysis of the phenotypic variability as well as impact of early diagnosis and treatment in six affected families with ALDH7A1 deficiency","volume":"12","author":"Jiao","year":"2021","journal-title":"Front. Genet."},{"key":"10.1016\/j.ymgme.2022.02.005_bb0190","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1017\/S0012162201000779","article-title":"Pyridoxine-dependent and pyridoxine-responsive seizures","volume":"43","author":"Baxter","year":"2001","journal-title":"Dev. Med. Child Neurol."},{"key":"10.1016\/j.ymgme.2022.02.005_bb0195","doi-asserted-by":"crossref","first-page":"e78","DOI":"10.1212\/WNL.0000000000005748","article-title":"Geometric morphometrics reveal altered corpus callosum shape in pyridoxine-dependent epilepsy","volume":"91","author":"Oesch","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.ymgme.2022.02.005_bb0200","article-title":"SPENT group, SPIRIT extension and elaboration for n-of-1 trials: SPENT 2019 checklist","volume":"368","author":"Porcino","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.ymgme.2022.02.005_bb0205","doi-asserted-by":"crossref","first-page":"160018","DOI":"10.1038\/sdata.2016.18","article-title":"The FAIR Guiding Principles for scientific data management and stewardship","volume":"3","author":"Wilkinson","year":"2016","journal-title":"Sci. Data."},{"key":"10.1016\/j.ymgme.2022.02.005_bb0210","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.ymgme.2015.12.007","article-title":"Metabolic diet app suite for inborn errors of amino acid metabolism","volume":"117","author":"Ho","year":"2016","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2022.02.005_bb0215","author":"Eiwitkenner"},{"key":"10.1016\/j.ymgme.2022.02.005_bb0225","series-title":"Treatable ID","year":"2021"},{"key":"10.1016\/j.ymgme.2022.02.005_bb0230","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/s13023-021-01727-2","article-title":"Treatable inherited metabolic disorders causing intellectual disability: 2021 review and digital app","volume":"16","author":"Hoytema van Konijnenburg","year":"2021","journal-title":"Orphanet J. Rare Dis."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719222001378?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719222001378?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,28]],"date-time":"2023-08-28T22:22:57Z","timestamp":1693261377000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719222001378"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":45,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["S1096719222001378"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2022.02.005","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Timing of therapy and neurodevelopmental outcomes in 18 families with pyridoxine-dependent epilepsy","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2022.02.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}